TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE DERMAL FILLERS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING DEMAND FOR ANTI-AGING THERAPEUTICS
5.1.2 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES
5.1.3 INCREASING NUMBER OF FACIAL VOLUME REPLACEMENT AND ENHANCEMENT PROCEDURES
5.1.4 INCREASING PREVALENCE OF FACIAL SOFT TISSUE DISEASE AND DISORDERS
5.1.5 GROWING AWARENESS FOR THE COSMETIC PROCEDURES
5.2 RESTRAINTS
5.2.1 STRINGENT REGULATION, GUIDELINES, STANDARDS FOR DERMAL FILLERS
5.2.2 HIGH COST OF PROCEDURES
?
5.3 OPPORTUNITIES
5.3.1 ADVANCEMENT IN THE DERMAL FILLERS
5.3.2 GROWING COSMETIC EXPENDITURE
5.3.3 RISING ACCIDENT CLAIMS FOR DERMAL FILLER INJURIES
5.4 CHALLENGES
5.4.1 INCREASING SIDE EFFECTS OF THE DERMAL FILLER
5.4.2 AVAILABILITY OF ALTERNATIVES
6 EUROPE DERMAL FILLERS MARKET, BY TYPE
6.1 OVERVIEW
6.2 SEMI-PERMANENT DERMAL FILLER
6.3 PERMANENT DERMAL FILLER
7 EUROPE DERMAL FILLERS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 BIODEGRADABLE DERMAL FILLERS
7.3 NON-BIODEGRADABLE DERMAL FILLERS
8 EUROPE DERMAL FILLERS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 FACIAL LINE CORRECTION
8.3 WRINKLES
8.4 LIP ENHANCEMENT
8.5 FACE LIFT
8.6 RHINOPLASTY
8.7 SCAR TREATMENT
8.8 SAGGING SKIN
8.9 CHEEK DEPRESSION
8.10 DENTISTRY
8.11 RECONSTRUCTIVE SURGERY
8.12 AESTHETIC RESTORATION
8.13 OTHERS
9 EUROPE DERMAL FILLERS MARKET, BY MATERIAL TYPE
9.1 OVERVIEW
9.2 NATURAL DERMAL FILLERS
9.2.1 HYALURONIC ACID
9.2.1.1 BY MATERIAL TYPE
9.2.1.1.1 SINGLE-PHASE
9.2.1.1.2 DUPLEX-PHASE


9.2.1.2 BY APPLICATION
9.2.1.2.1 FACIAL LINE CORRECTION
9.2.1.2.2 WRINKLES
9.2.1.2.3 LIP ENHANCEMENT
9.2.1.2.4 FACE LIFT
9.2.1.2.5 RHINOPLASTY
9.2.1.2.6 SCAR TREATMENT
9.2.1.2.7 SAGGING SKIN
9.2.1.2.8 CHEEK DEPRESSION
9.2.1.2.9 DENTISTRY
9.2.1.2.10 RECONSTRUCTIVE SURGERY
9.2.1.2.11 AESTHETIC RESTORATION
9.2.1.2.12 OTHERS
9.2.2 FAT
9.2.2.1 BY APPLICATION
9.2.2.1.1 FACIAL LINE CORRECTION
9.2.2.1.2 WRINKLES
9.2.2.1.3 LIP ENHANCEMENT
9.2.2.1.4 FACE LIFT
9.2.2.1.5 RHINOPLASTY
9.2.2.1.6 SCAR TREATMENT
9.2.2.1.7 SAGGING SKIN
9.2.2.1.8 CHEEK DEPRESSION
9.2.2.1.9 DENTISTRY
9.2.2.1.10 RECONSTRUCTIVE SURGERY
9.2.2.1.11 AESTHETIC RESTORATION
9.2.2.1.12 OTHERS
9.2.3 COLLAGEN
9.2.3.1 BY APPLICATION
9.2.3.1.1 FACIAL LINE CORRECTION
9.2.3.1.2 WRINKLES
9.2.3.1.3 LIP ENHANCEMENT
9.2.3.1.4 FACE LIFT
9.2.3.1.5 RHINOPLASTY
9.2.3.1.6 SCAR TREATMENT
9.2.3.1.7 SAGGING SKIN
9.2.3.1.8 CHEEK DEPRESSION
9.2.3.1.9 DENTISTRY
9.2.3.1.10 RECONSTRUCTIVE SURGERY
9.2.3.1.11 AESTHETIC RESTORATION
9.2.3.1.12 OTHERS
9.2.4 OTHERS
9.2.4.1 BY APPLICATION
9.2.4.1.1 FACIAL LINE CORRECTION
9.2.4.1.2 WRINKLES
9.2.4.1.3 LIP ENHANCEMENT
9.2.4.1.4 FACE LIFT
9.2.4.1.5 RHINOPLASTY
9.2.4.1.6 SCAR TREATMENT
9.2.4.1.7 SAGGING SKIN
9.2.4.1.8 CHEEK DEPRESSION
9.2.4.1.9 DENTISTRY
9.2.4.1.10 RECONSTRUCTIVE SURGERY
9.2.4.1.11 AESTHETIC RESTORATION
9.2.4.1.12 OTHERS
9.3 SYNTHETIC DERMAL FILLERS
9.3.1 POLY-L-LACTIC ACID
9.3.1.1 BY APPLICATION
9.3.1.1.1 FACIAL LINE CORRECTION
9.3.1.1.2 WRINKLES
9.3.1.1.3 LIP ENHANCEMENT
9.3.1.1.4 FACE LIFT
9.3.1.1.5 RHINOPLASTY
9.3.1.1.6 SCAR TREATMENT
9.3.1.1.7 SAGGING SKIN
9.3.1.1.8 CHEEK DEPRESSION
9.3.1.1.9 DENTISTRY
9.3.1.1.10 RECONSTRUCTIVE SURGERY
9.3.1.1.11 AESTHETIC RESTORATION
9.3.1.1.12 OTHERS
9.3.2 CALCIUM HYDROXYLAPATITE
9.3.2.1 BY APPLICATION
9.3.2.1.1 FACIAL LINE CORRECTION
9.3.2.1.2 WRINKLES
9.3.2.1.3 LIP ENHANCEMENT
9.3.2.1.4 FACE LIFT
9.3.2.1.5 RHINOPLASTY
9.3.2.1.6 SCAR TREATMENT
9.3.2.1.7 SAGGING SKIN
9.3.2.1.8 CHEEK DEPRESSION
9.3.2.1.9 DENTISTRY
9.3.2.1.10 RECONSTRUCTIVE SURGERY
9.3.2.1.11 AESTHETIC RESTORATION
9.3.2.1.12 OTHERS
9.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
9.3.3.1 BY APPLICATION
9.3.3.1.1 FACIAL LINE CORRECTION
9.3.3.1.2 WRINKLES
9.3.3.1.3 LIP ENHANCEMENT
9.3.3.1.4 FACE LIFT
9.3.3.1.5 RHINOPLASTY
9.3.3.1.6 SCAR TREATMENT
9.3.3.1.7 SAGGING SKIN
9.3.3.1.8 CHEEK DEPRESSION
9.3.3.1.9 DENTISTRY
9.3.3.1.10 RECONSTRUCTIVE SURGERY
9.3.3.1.11 AESTHETIC RESTORATION
9.3.3.1.12 OTHERS
9.3.4 POLYALKYLIMIDE
9.3.4.1 BY APPLICATION
9.3.4.1.1 FACIAL LINE CORRECTION
9.3.4.1.2 WRINKLES
9.3.4.1.3 LIP ENHANCEMENT
9.3.4.1.4 FACE LIFT
9.3.4.1.5 RHINOPLASTY
9.3.4.1.6 SCAR TREATMENT
9.3.4.1.7 SAGGING SKIN
9.3.4.1.8 CHEEK DEPRESSION
9.3.4.1.9 DENTISTRY
9.3.4.1.10 RECONSTRUCTIVE SURGERY
9.3.4.1.11 AESTHETIC RESTORATION
9.3.4.1.12 OTHERS
9.3.5 OTHERS
9.3.5.1 BY APPLICATION
9.3.5.1.1 FACIAL LINE CORRECTION
9.3.5.1.2 WRINKLES
9.3.5.1.3 LIP ENHANCEMENT
9.3.5.1.4 Face Lift
9.3.5.1.5 RHINOPLASTY
9.3.5.1.6 SCAR TREATMENT
9.3.5.1.7 SAGGING SKIN
9.3.5.1.8 CHEEK DEPRESSION
9.3.5.1.9 DENTISTRY
9.3.5.1.10 RECONSTRUCTIVE SURGERY
9.3.5.1.11 AESTHETIC RESTORATION
9.3.5.1.12 OTHERS
10 EUROPE DERMAL FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.2 SCULPTRA
10.2.3 RADIESSE
10.2.4 RESTYLANE
10.2.5 BELLAFILL
10.2.6 PURAGEN
10.2.7 ELEVESS
10.2.8 AQUAMID
10.2.9 OTHERS
10.3 GENERIC
11 EUROPE DERMAL FILLERS MARKET, BY END USER
11.1 OVERVIEW
11.2 DERMATOLOGY CLINICS
11.3 AMBULATORY SURGICAL CENTERS
11.4 HOSPITALS
11.5 OTHERS
12 EUROPE DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DRUG STORES
12.3 RETAIL PHARMACY
12.4 ONLINE PHARMACIES
?
13 EUROPE DERMAL FILLER MARKET, BY GEOGRAPHY
13.1 EUROPE
13.1.1 GERMANY
13.1.2 ITALY
13.1.3 FRANCE
13.1.4 UNITED KINGDOM
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 NETHERLANDS
13.1.8 SWITZERLAND
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 REST OF EUROPE
14 EUROPE DERMAL FILLERS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 COMPANY PROFILE
15.1 ALLERGAN
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 GALDERMA LABORATORIES, L.P.
15.2.1 COMPANY SNAPSHOT
15.2.2 COMPANY SHARE ANALYSIS
15.2.3 BRAND PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 MERZ PHARMA
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 ANIKA THERAPEUTICS, INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
?
15.5 BIOHA LABORATORIES
15.5.1 COMPANY SNAPSHOT
15.5.2 PRODUCT PORTFOLIO
15.5.3 RECENT DEVELOPMENTS
15.6 BIOPLUS CO., LTD.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 BIOXIS PHARMACEUTICALS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 CONTURA LTD.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 CROMA-PHARMA GMBH
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.10 HUMEDIX.CO.LTD (A SUBSIDIARY OF HUONS EUROPE)
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 PROLLENIUM MEDICAL TECHNOLOGIES
15.11.1 COMPANY SNAPSHOT
15.11.2 BRAND PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 SCULPT LUXURY DERMAL FILLERS LTD
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE CO., LTD.)
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 SUNEVA MEDICAL
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 TEOXANE
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO.,LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS